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Objective: Persons with dementia are at risk of malnutrition, evidenced by low dietary intake, which has con-
sequences for nutritional status, activity of daily living and disease progression. The effects of oral nutrition
supplements (ONS) on nutritional intake, nutritional status, and cognitive and physical outcomes in older
persons with dementia were evaluated.
Methods: PubMed, Medline, Embase, CINAHL and the Cochrane Central Register of Controlled Trials were
searched in December 2017, and this was repeated in May 2019. The Preferred Reporting Items for System-
atic Reviews and Analysis (PRISMA) checklist was used. Papers were considered if they presented experi-
mental clinical trials using oral nutritional supplements to persons diagnosed with dementia, including
Alzheimer's disease and mild cognitive impairment, and conducted in hospitals, nursing homes or homes.
Results: We included ten articles reporting nine clinical trials. A total of 407 persons with dementia were
included, of whom 228 used ONS for 7 to 180 days. Nutritional intake improved by 201 to 600 kcal/day.
Energy intake from ordinary foods was not affected, thus ONS improved the persons daily intake of energy
and protein. Body weight, muscle mass, and nutritional biomarkers in blood improved in the intervention
groups compared with the control groups. No effects on cognition or physical outcomes were observed.
Conclusion: ONS increases the intake of energy and protein and improves nutritional status in persons with
dementia; however, RCTs with longer intervention periods are needed to investigate the impact on cognitive
and functional outcomes.
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Dementia is a chronic condition characterised as a decline in cog-
nitive functioning that leads to dependence in the performance of
daily activities, including nutritional sufficiency.1 More than 46 mil-
lion people in the world have dementia, and the number is projected
to increase to 152 million by 2050.2 The incidence of dementia
increases progressively with age.3People with dementia often experience several problems related
to nutrition. In the early stages, issues with memory and thoughts
may affect planning, shopping, and preparation of food. As the dis-
ease progresses, eating and drinking may become more difficult. Dys-
phagia has been reported in 13 to 57% of persons with dementia.4
Sensory failure, loss of appetite, and eating skills are other common
symptoms.4,5 Difficulties in communicating discomfort due to, e.g.,
hunger, pain, tiredness, medication, and constipation can also nega-
tively affect the intake of food and fluid.4,5 Confusion about where
they are and who they are with may cause agitation and increased
energy needs.4,5 Consequently, people with dementia lose weight
and increase the risk of malnutrition as the condition progresses.4
Malnutrition is a state resulting from a lack of intake or uptake of
nutrition that leads to altered body composition and body cell mass
and, subsequently, diminished physical and mental function and
impaired clinical outcomes.6 The presence of malnutrition may acceler-
ate the progression of dementia, as a lack of energy and micronutrients,
118 R.J. Tangvik et al. / Geriatric Nursing 42 (2021) 117123such as vitamin B12, folic acid, thiamine, and others, contributes to
impaired cognition and aggravation of existing impairments.7 Muscle
waste leads to functional decline and frailty, which are in turn associ-
ated with a loss of independence, increased risk of morbidity and
mortality.4,8,9
Oral nutrition supplements (ONS), classified as food for special
medical purposes to manage disease-related malnutrition, is one out
of several ways to aid the person in reaching their nutritional goals.
The goal of ONS is to enrich the person’s dietary intake without sup-
pressing it or replacing feeding assistants or meal provisions. ONS
have been shown to improve nutritional intake and nutritional status
in persons with insufficient dietary intake and reduce complications
such as pressure sores, infection, venous thrombosis, pulmonary
embolism and confusion;10,11 however, studies regarding the effect
of ONS on persons with dementia are lacking.
Aim
The overall aim was to investigate the effects of ONS on nutri-
tional intake and clinical outcomes in older persons with dementia. A
systematic review was conducted, and the following research ques-
tions (RQs) were addressed: What effects do ONS have on total die-
tary intake and consumption of voluntary food intake (RQ1)? What
effects do ONS have on nutritional status (RQ2)? What effects do ONS
have on cognitive or functional outcomes (RQ3)?
Methods
The study protocol for this review was registered on PROSPERO,
registration number CRD42019082493. The Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) statement
were used to identify, screen, evaluate, and include papers for this
review.12,13 Inclusion and exclusion criteria are presented in Table 1,
and Fig. 1 shows the inclusion process.
The identification process included search strategies inspired by
the article of Droogsma14 and developed after preliminary searches
discussed by the authors. See Appendix 1 for the entire search strategy.
The literature searches were conducted in PubMed, Medline, Embase,
CINAHL and the Cochrane Central Register of Controlled Trials in
December 2017 and May 2019. The MeSH terms “Alzheimer's Disease”
or “Dementia” were combined with (“Malnutrition” or “Body Weight”
or “Weight Loss” or “Thinness” or “Body Weight Changes”) and (“Diet
Therapy” or “Dietary Supplements” or “Nutritional Support” or “Food,
fortified” or “Eating”). No year or language limitation was placed on
the search, and only publications such as conference abstracts, editori-
als, and letters were excluded during the identification process. The
search results were collected in Endnote, and duplicates were removed
using both automatic and manual procedures.Table 1
Inclusion and exclusion criteria
Criteria Inclusion criteria
Population Persons with dementia, Alzheimer's disease or impaired cognitive functi
18 years or older
Intervention ONS
Comparators Placebo or treatment as usual
Outcome Objective and measurable effect on dietary intake, nutrition status, cogni
and/or functional outcomes
Timing Any duration of the intervention
Setting Hospitalised, living in nursing homes or home dwelling
Study design Experimental clinical trials, including RCTs and cross-over study designs
Other English or Scandinavian language
ONS, oral nutrition supplementsDuring the screening step, conducted by Rayyan,15 title and
abstracts were read for relevance, and inappropriate articles were
excluded due to the criteria (Table 1). Two pairs of reviewers (RT and
FB; JD and KK) performed the screening, which was completed inde-
pendently (blinded). Disagreements within the pairs of reviewers
were resolved through discussion, and a third reviewer was available
when needed. The articles’ eligibility was assessed by the same pairs
of reviewers who read them in full text (Table 1).
Quality assessment was performed by using the Critical Appraisal
Skills Program (CASP) checklists for randomised control trials (RCT),
cross-over trials and case-control studies.16 These checklists include
quality assessment components regarding aims, participants, clinical
outcomes and methodological issues, and relevance of results. For
each article, two reviewers independently assessed quality by
answering 10 subcategories with “yes,” “can't tell,” or “no.” Any dis-
crepancies in component ratings were resolved through discussion
between reviewers and then the expert opinion of the group, if
required. The quality rating for the studies in this review was overall
high, and no articles were excluded after quality assessment.
Data extraction
Information extracted from the articles encompassed study design,
setting, population size, participants’ demographic data, and details of
the intervention as presented in Table 2. Table 3 presents themean daily
consumption of energy and protein from the ONS intervention and
changes in the mean outcome’s variables. The effects of ONS on nutri-
tional intake was reported by mean intake of energy and protein at
baseline compared with intake at the end of intervention. Intake of
energy and protein at the end of the follow-up period were investigated
in cases where this was reported. The effects of ONS on nutritional sta-
tus was described by changes in the results of the mini nutritional
assessment (MNA), nutrition score index (NuSc), body weight, body
mass index (BMI), muscle mass (MUAMC), body fat (TSF) and nutritional
biomarkers in blood. The MNA is specifically developed to be used in
frail older adults. Based on the scores, persons are classified as malnour-
ished (<17 points), at risk of malnutrition (17 to 23.5 points), or well-
nourished (34 to 30 points).17 The NuSc is calculated by giving one score
to each variable (body mass index (BMI), triceps skinfold (TSF), arm
muscle circumference (AMC), albumin, transferrin, and IGF-I) below the
reference range. A NuSc of 0 indicates a well-nourished state, while a
NuSc of 1 or 2 indicates a risk of malnutrition and a NuSc 3 denotes
malnutrition.18 Muscle mass (mid-upper-arm muscle circumference
(MUAMC)) is calculated by mid-upper-arm circumference (MUAC) and
TSF: MUAMC =MUAC (cm) - 0.3142£ TSF (mm).
Several screening tools were used to report the effects of ONS on
cognitive or functional outcomes. The Mini-Mental State Examination
(MMSE) tool assesses orientation, memory, and other cognitive skillsExclusion criteria
on, Animal study
Low income countries
Patients with end-stage diseases such as cancer, chronic obstructive
pulmonary disease (COPD), and other
ONS without micronutrients, ONS with only one macronutrient, or not
using ONS
tive
Qualitative study design or case report
Abstract only or conference proceedings
Fig. 1. Flow-chart of study identification and inclusion.
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sion of the disease.19 MMSE scores range from 0 to 30. A score of <20
points is usually considered to be indicative of clinically significant
cognitive impairment.18 Functional status and the level of indepen-
dence was reported by the Barthel index (BI). The scores indicated
independence (100 points), slight dependence (65 points) and
moderate (45 to 60 points), severe (20 to 45 points) and total depen-
dence (<20 points).
Data management
The nutritional value of the ONS intervention presented in Table 3
is based on information from the nutritional prescription and compli-
ance listed in Table 2. The study’s results from ONS intervention are
presented in Table 3. Changes in outcome measurements were the
difference between baseline values and the values at the end of the
intervention in both the intervention group and the control group.
Thus, the effect of ONS are expressed both within and between the
groups.
Results
Out of 2669 eligible articles, 104 articles were read in full (Fig. 1).
Finally, ten publications were included in the review reporting on
nine experimental clinical studies: six RCTs and three non-RCTs.18-27One study reported peri- and post-intervention effects in two sepa-
rate articles.19,27
Description of the included studies
The study participants were either living at home,19,23,24,27 in
nursing homes,18,20,26 or in geriatric hospitals.19-22,25,27 The reported
outcomes were dietary intake,19,20,24,27 nutritional status18,21-27 and
cognitive or functional status.18,22-24,26,27 The publication years
ranged from 1995 until 2017, with seven European, two Canadian
and one Brazilian article(s). All included studies were approved by
the Committee of The Ethics of Medical Research, and all except one
reported that all subjects and/or their representatives had signed an
informed consent form.
Table 2 summarises the characteristics of the included articles. A
total of 407 persons, 60 years or older and 75% female, participated in
the nine clinical trials: 171 in the intervention groups, 179 in the con-
trol groups, and 57 who were their own control in the two cross-over
studies. Nutritional status was reported according to MNA,2224 low
BMI,21,26 NuSc18 or not reported.19,20,25,27 ONS provided 250 to
850 kcal and 9 to 42 g of protein per day for 7 to 180 days. Compli-
ance with the prescription was 98 to 100% in five RCTs,2124,26 70 to
89% in four non-RCTs1820,27 and unreported in one study.25 In addi-
tion to reporting the effects of ONS post supplementation, the effects

















































































































































































































































































































































































































































































































































































































































































































































































































120 R.J. Tangvik et al. / Geriatric Nursing 42 (2021) 117123were reported. Four studies used multiple interventions that
included staff education18,24,25 or psycho-motor rehabilitation.23Effects of ONS on dietary intake
Three studies revealed an improved intake of energy and protein
due to the intervention with ONS.20,24,27 In the study by Allen and co-
workers,20 the energy intake was 1238 (§ 512) kcal/d on control
days and 1755 (§ 644) kcal/d on intervention days. The intake of pro-
tein was 47.5 (§ 20.4) g/d and 73.4 (§ 29.5) g/d on control days and
intervention days, respectively. Thus, during consumption of ONS,
56% of the persons met the recommended daily allowance for energy,
with 74% acquiring the necessary protein, compared to 17% and 34%
during the control period.20 Lauque reported energy intake to be
1476 (§ 380) kcal/d at baseline and 291 (§ 481) kcal more per day at
the end of the intervention. Three months post intervention, daily
energy intake was close to the baseline at 1547 (§ 42.5) kcal/d. The
participants' intake of energy was 28 kcal/kg body weight (BW) at
baseline and 33 kcal/kg BW during the intervention.24 Two
studies19,24 reported a minor improvement in dietary intake of 22.7
(§ 108.7) kcal/d for seven days post supplementation and 87
(§ 419) kcal/d for three months post supplementation. In two cross-
over studies, the intake of ordinary food was slightly reduced during
the intervention period compared to the control period.20,27 Partici-
pants with the lowest BMIs were more likely to reduce their food
intake when using ONS.27Effects of ONS on nutritional status
Eight studies found significant improvements in nutritional status
due to ONS. Individual nutrition risk status improved,22,23 although
the prevalence of malnutrition risk was not affected.18,23 Even the
categorisation of malnutrition was not affected, and the MNA-scores
improved in the intervention group compared with the control
group: 1.4 (§ 0.8) score vs. 0 (§ 0.1) score,22 and 0.4 (§ 0.8) vs. -0.1
(§ 1.1) score, both respectively.23
Mean body weight (BW) improved, with a range of 0.3 to 6.7 kg
from baseline to end of the intervention, compared with a range of
-2.2 to 0.97 kg in the control groups.18,21,22,24-27 In other words, the
prescription of 680 kcal/d for 180 days resulted in a mean weight
gain of 6.7 kg in the intervention group compared with -2.2 kg in the
control group.25
Muscle mass improved in three out of six studies investigating
this.18,2125 The MUAMC changed by 0.2 (§ 0.4) cm from baseline to
post intervention in the intervention group and -0.2 cm (§ 0.8) in the
control group after 3 weeks with ONS.22 After ONS for six months,
muscle mass improved by 3.43 cm in the intervention group compared
to -0.19 cm in the control group. Otherwise, no muscle gain was
reported; however, Faxen-Irving reported that female controls lost
more muscle mass than females on ONS.18 Also, body fat (TSF)
improved by 2.5 mm among female participants in the intervention
group and declined by 0.6 mm among the female controls.18 After ONS
for three weeks, TSF changed by 0.4 (§ 0.5) mm in the intervention
group and 0.0 (§ 0.1) mm in the control group, de Sousa reported.22
The remaining studies reported no changes in body fat.21,23,25
Nutritional biomarkers were investigated in five studies.18,22,24-26
The changes in the albumin levels were inconsistent; however, three
studies reported that the albumin improved by a range of 0.34 to
1.3 g/L during intervention.22,24,25 Faxen-Irving reported an overall
reduction in nutritional biomarkers, which was most pronounced in
the control group.18 In addition, Wouters-Wesseling reported
improved levels of homocysteine, thiamine diphosphate, vitamin B6,
vitamin B12, folic acid, and vitamin D in the intervention group com-
pared with the control group.26
Table 3
Results








(RQ2) (ΔI vs. ΔC)
Cognitive and physical function
(RQ3) (ΔI vs. ΔC)
Allen 2013 595 kcal/29 g E: 517 kcal/d*
P: 2 g/d*
n.r. n.r. n.r.
Carver 1995 600 kcal/20 g n.r. BW: 3.5* vs. 0.6 kg
MUAMC: 0.5 vs. 0 cm
TSF: 1.5 vs. 0.5 mm
n.r. n.r.
Faxen-Irving 2002 361 kcal/16 g n.r. BW: 3.4 vs. -0.3 kg**
TSF-W: 2.6 vs. -0.7 mm**
TSF-M: 1.0 vs. n.r.
MUAMC-W: -0.1 vs. -0.5 cm
MUAMC-M: -0.6 vs. n.r. cm
S-albumin: -2 vs. -2.6 g/l**
S-transferrin: -0.1 vs. 0 g/l
S-Hb: -1 vs. -4 g/l**
Vit B12: 37 vs. 0 pmol/l
IGF-1: -5 vs. -4 mg/l
ADL: E to F vs. D to E
MMSE: -2.5 vs. 0.5**
Lauque 2004 368 kcal/n.r. E: 291 vs. -1 kcal/d**
P: 16 vs. -3 g/d**
E2: 87 vs. 178 kcal/d*
P2: 17 vs. 1 g/d
BW: 1.9 vs. 0.4 kg**
FFM: 0.8 vs. 0.2 kg
MNA: 3.4 vs. 1.9 scores**
S-albumin: 0.34 vs. -0.21 g/ MMSE: 0.3 vs. -0.4
ADL: -0.2 vs. -0.3
Pivi 2011 n.r. n.r. BW: 6.7 vs. -2.2 kg**
MUAMC: 3.4 vs. -0.2 cm**
TSF: 1.4 vs. 2.2 mm
S-protein: 4.3 vs. 0.1 mg/dl**
S-albumin: 0.7 vs. -1.2 g/l
n.r.
de Sousa 2012 400 kcal/18 g n.r. BW: 2.1 vs. 0 kg**
TSF: 0.4 vs. 0 mm**
MUAMC: 0.2 vs. -0.2 cm**
MNA: 1.4 vs. 0 scores**
S-albumin: 1.1 vs. -0.7 % g/l**
S-protein: 0.2 vs. 0 g/dL**
Vit B12: 233 vs. 221 ng/ml
Folic acid: 2.7 vs. 4.0 ng/ml
MMSE: 0 vs. 0
ADL(v/BI): 0 vs. -0.7
de Sousa 2017 300 kcal/12 g n.r. BW: 0.3 vs. 0.1 kg**
MNA: 0.4 vs. -0.1 scores**
TSF: 0 vs. 0.7 mm
MUAMC: 0 vs. -0.3 cm
FFM: -0.3 vs. -0.1 kg
L(v/BI): 0 vs. -0.3
MMSE: -0.2 vs. 0
Wouters-Wesseling
2002
268 kcal/8 g n.r. BW: 1.4 vs. -0.8 kg** Vit B1: 0.5 vs. -0.1 nmol/
Vit B6: 114 vs. 8.3** nmol/l
Vit B12: 129.5 vs. -1** pmol/l
Folic acid: 23.4 vs. 0.3** nmol/l
Vit D: 29.4 vs. 13.4** nmol/l
S-albumin: 1.3 vs. 1.4 g/l
ADL(v/BI): 0 vs. -0.5
Young 2004 201 kcal/9 g E: 154 kcal/d*
P: 7 g/d
BW: 0.97 kg* n.r. n.r.
Parrott 2006 201 kcal/n.r. E3: 23 kcal/d* BMI: 23.7 vs. 24.3 kg/m2* n.r. n.r.
Δ The difference from baseline to end of the intervention period. Cross-over studies reported from the intervention period only. *statistic within-significance, **statistic between-
significance.
Abbreviations: RQ=research questions, I=intervention group, C=control group, BW=body weight, BMI=body mass index, E=energy, P=protein, E2=energy three months after the end
of the intervention, P2=protein three months after the end of the intervention, E3=energy seven days after the end of the intervention, TSF=triceps skinfold, TSF-W=triceps skinfold
women, TSF-M=triceps skinfold men, MUAMC=mid-upper-arm muscle circumference, MUAMC-W=mid-upper-arm muscle circumference women, MUAMC-M=mid-upper-arm
muscle circumference men, MUAC=mid-upper-arm circumference, IGF-1=insulin-like growth factor-1, FFM=fat-free mass. Tests: MMSE=mini mental state examination, BI=Barthel
index, ADL=activities of daily living level of dependence, EBS=eating behaviour scale, NuSc=nutritional score index, MNA=mini nutritional assessment, n.r.=not reported.
R.J. Tangvik et al. / Geriatric Nursing 42 (2021) 117123 121Effects of ONS on cognitive and functional status
The effects of ONS on cognitive function were inconsistent in the
four studies that investigated this. Faxen-Irving reported a decline in
the MMSE scores in the intervention group compared to the control
group (-2.5 scored vs. 0.5 scores, respectively),18 and Lauque reported
improved MMSE scores (0.33 (§ 2.88)) in the intervention group and
decreased scores (-0.41 (§ 2.56)) in the control group.24 No signifi-
cant effects of nutritional treatment on functional status were
reported in the five articles,18,22-24,26 see Table 3.
Discussion
The findings of this systematic review focus on persons with
dementia, of whom most were undernourished. It shows that ONS
improved daily intake of energy and protein, compliance was high,
and more persons met the recommended nutrition intake. Overall,
intervention with ONS improved nutritional status; however, no
effects on cognitive or functional outcomes were reported.
Compliance with the intervention was generally high. Considering
the multiple factors contributing to limit dietary intake in these
patients, compliance with nutrition intervention is important. We
did not find a lower consumption of ONS in long lasting studies, asreported by Allen.28 Hence giving ONS might have been implemented
in daily routines in the studies included in this review. However,
study design might influence the results, as the RCT-studies reported
98100% compliance compared to 7089% in the non-RCTs. It might
be a dilemma that persons with higher BMI, fewer motor problems,
fewer mental disorders, and increased attention consumed more
ONS than subjects with more pronounced needs, such as persons
with lower BMI and reduced physical and mental function.27 The
most frail persons are in greater need of a proper follow-up regarding
nutrition. In addition, Hubbard reported the following instructions to
be of importance for compliance among older persons: “take in small
doses, take ad libitum, take at set times and as part of medicine
rounds”. Additionally, offering a variety of flavours was reported to
positively correlate with compliance.29 The studies included in the
present review used the following precautions to improve compli-
ance to intervention: 1) giving ONS after/between ordinary
meals,18,22,26,27 2) dispersing ONS throughout the day,22,26 and 3)
removing ONS one hour before the next meal.20 We assumed that
not using ONS before ordinary meals have been a success factor for
these studies.
The major finding that ONS improved dietary intake without sup-
pressing the intake of ordinary food has high relevance, as the dietary
intake of energy and protein was worryingly low in this population,
122 R.J. Tangvik et al. / Geriatric Nursing 42 (2021) 117123and solutions to improve intake are valued. This finding is in line with
the results of two earlier systematic reviews10,30 reporting ONS to
increase the intake of energy and protein without noteworthy sup-
pression of the intake of ordinary food. However, and in contrast to
people with high BMI (BMI >25 kg/m2), persons with low and even
normal BMI (BMI <25 kg/m2) were more likely to reduce dietary
intake when using ONS.27 Still, and in line with nutrition guidelines,4
we suggest ONS contributes to enriched mealtimes, modified meal-
time environment, eating assistance to improve nutrition intake in
malnourished patients and even more prevent malnutrition in at-risk
patients.
The finding of ONS’s contribution to maintain and even increase
BW and muscle mass in persons with dementia is also highly rele-
vant. Weight loss in older people is often an indication of muscle
waste and is associated with an increased risk of institutionalisation,
morbidity, mortality,31,32 falls, disabilities, and fractures.33 Weight
loss is common in people with dementia, as they experience several
challenges with dietary intakes, such as loss of eating skills, difficul-
ties in communicating, constipation, aspiration due to dysphagia, and
increased needs due to restlessness.4,18,23 Therefore, an effort to
maintain body weight and muscle mass is given priority in ESPEN
guidelines on nutrition in persons with dementia,4 and we suggest
ONS to be beneficial for this purpose.
The results regarding the effect of ONS on cognition were incon-
sistent in the present review. Available evidence regarding the effects
of ONS on cognitive function is very limited. However, studies have
reported an association between malnutrition and cognitive decline
in persons with dementia, 34-36 and supplementation of specific
nutrients is shown to delay this process.37 Thus, we cannot exclude
the possibility that ONS over a longer period would have given other
results. Our suggestion is to perform studies using sensitive scales for
cognitive function to study the effects of long-lasting individualised
nutritional therapy.
After a femoral neck fracture in lean older women, the activity of
daily living (ADL) declined less in the intervention group treated
with ONS for 6 months than in the control group.38 It can be assumed
that by improving nutritional status in patients with dementia, gen-
eral condition and function will also improve. This is, however, not
confirmed by this review. A number of factors such as amount, com-
position and duration of the intervention; patients nutritional status;
and type and stage of dementia may explain the lack of benefits.
Nutritional intake and status are essential to preserve a person’s
independence for as long as possible, and more studies should inves-
tigate the effects of ONS on functional outcomes in persons with
dementia.
Strength and limitations
The major strength of this review is the high compliance with the
intervention and high proportion of included studies using the RCT
design. In one study, a double-blinded study design was used to
reduce intervention bias.26 The limitation of this review was the rela-
tively small sample size in the included studies, the variation in the
nutritional content of ONS, the intervention duration, and the insuffi-
cient report of the participants' nutritional risk status. Moreover, the
included studies were relatively old. Despite a new search performed
in 2019, no new studies were found. The variation in the presentation
of outcome measurements precluded a meta-analysis of the included
studies.
Clinical implications
A growing body of evidence provides support for lifestyle modifi-
cations such as social interactions, mental and physical exercise, and
nutritional supplements in delaying cognitive decline.37 This reviewreveals that persons with dementia will profit from ONS as nutri-
tional intake, body weight, and muscle mass improved; nevertheless,
individual nutritional needs were often still not met. To ensure every
individual’s nutritional needs are fulfilled, we therefore suggest the
following routines: 1) nutritional risk screening and assessment to
make individual nutrition care plans for persons with such needs; 2)
initiation of nutritional treatment such as enriched mealtimes, modi-
fied mealtime environment, eating assistant and ONS; 3) systematic
monitoring and communication of nutritional issues; and 4) nutrition
educated staff to handle this important part of patient treatment.
Such routines have been found to have a significant effect on hospi-
talised patients39 and should be a part of dementia care as well.
Conclusion
Intervention with ONS increased energy and protein intake in per-
sons with dementia. Nevertheless, not all persons met their individ-
ual needs. The nutritional status improved, although no effects on
functional or cognitive outcomes were observed. A more comprehen-
sive intervention plan for people with cognitive impairments should
address the individual nutritional challenges to systematically meet
nutritional needs. This should be tested in high-quality RCTs to inves-
tigate the impact on functional and clinical outcomes.
Supplementary materials
Supplementary material associated with this article can be found
in the online version at doi:10.1016/j.gerinurse.2020.12.005.
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